CS logo
small CS logo
Hospital Cardiologica Aguascalientes

Aguascalientes, Mexico
General hospital in Aguascalientes
República de Ecuador 200, Las Américas, 20230 Aguascalientes, Ags.

About Hospital Cardiologica Aguascalientes


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Hospital Cardiologica Aguascalientes


During the past decade, Hospital Cardiologica Aguascalientes conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 20 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 14 clinical trials were completed. i.e. 155.6% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3
2001-12-01
Completed
1,300
Study of a New Protease Inhibitor, BMS-232632, in Combination With Other Anti-HIV Drugs
1999-03-01
2001-12-01
Completed
A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease
Completed
240
Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial
Completed
750
A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past
Completed
320
A Study of Indinavir Taken With or Without DMP 266
Completed
300
The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT
Completed
325
Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients
Completed
200

Rows per page:

1–100 of 756

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hospital Cardiologica Aguascalientes" #1 sponsor was "Boehringer Ingelheim" with 10 trials, followed by "Allergan" with 4 trials sponsored, "Pfizer" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Bayer" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Cardiologica Aguascalientes" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Hospital Cardiologica Aguascalientes


According to Clinical.Site data, the most researched conditions in "Hospital Cardiologica Aguascalientes" are "Gastroparesis" (4 trials), "COVID-19" (3 trials), "Cardiovascular Disease" (3 trials), "Diabetes Mellitus" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "Hospital Cardiologica Aguascalientes" in a lesser frequency.

Clinical Trials Intervention Types at Hospital Cardiologica Aguascalientes


Most popular intervention types in "Hospital Cardiologica Aguascalientes" are "Drug" (26 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (20 trials), "Empagliflozin" (3 trials), "Relamorelin" (3 trials), "bococizumab (PF-04950615)" (2 trials) and "Alteplase" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital Cardiologica Aguascalientes


The vast majority of trials in "Hospital Cardiologica Aguascalientes" are 27 trials for "All" genders.

Clinical Trials Status at Hospital Cardiologica Aguascalientes


Currently, there are NaN active trials in "Hospital Cardiologica Aguascalientes". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Hospital Cardiologica Aguascalientes, undefined suspended trials, and 10 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Cardiologica Aguascalientes, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status